Company
Nitrase Therapeutics
Pioneering Medicines Through Groundbreaking Nitrase Biology
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- nitrasetx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Nitrase Therapeutics is a clinic-ready biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes discovered in-house with promise against a broad variety of diseases.
Funding snapshot
- Total raised
- $83MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $45M2021-11-02
Funding rounds
- Series A
- $45M2021-11-02, Company stated
- Series A
- $38M2020-04-21, Company stated
Products
- Other
- NDC-0524
Loading relationship preview